Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline-Reference-Cited by-同舟云学术

Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline

Published:2016-01-20 Issue:2 Volume:90 Page:105-117
ISSN:0009-9163
Container-title:Clinical Genetics
language:en
Short-container-title:Clin Genet

Author:

van Os N.J.H.¹,Roeleveld N.²³,Weemaes C.M.R.³,Jongmans M.C.J.⁴,Janssens G.O.⁵,Taylor A.M.R.⁶,Hoogerbrugge N.⁴,Willemsen M.A.A.P.¹

Affiliation:

1. Department of Neurology - Pediatric Neurology, Donders Institute for Brain, Cognition and Behaviour; Nijmegen The Netherlands

2. Department for Health Evidence, Radboud Institute for Health Sciences; Nijmegen The Netherlands

3. Department of Pediatrics, Radboudumc Amalia Children's Hospital; Nijmegen The Netherlands

4. Department of Human Genetics, Radboud Institute for Molecular Life Sciences; Radboud university medical center; Nijmegen The Netherlands

5. Department of Radiation Oncology; University Medical Center Utrecht and Princess Maxima Center for Pediatric Oncology; Utrecht The Netherlands

6. School of Cancer Sciences; University of Birmingham; Birmingham UK

Publisher

Wiley

Subject

Genetics (clinical),Genetics

Reference68 articles.

1. A single ataxia telangiectasia gene with a product similar to PI-3 kinase;Savitsky;Science,1995

2. Ataxia-telangiectasia; a familial syndrome of progressive cerebellar ataxia, oculocutaneous telangiectasia and frequent pulmonary infection;Boder;Pediatrics,1958

3. Cancer risk in ATM heterozygotes: a model of phenotypic and mechanistic differences between missense and truncating mutations;Gatti;Mol Genet Metab,1999

4. Breast and other cancers in families with ataxia-telangiectasia;Swift;N Engl J Med,1987

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ATM pathway in cancer: Opportunities, challenges and personalized therapeutic strategies;Cancer Treatment Reviews;2024-09

2. Multigenic panels in breast cancer: Clinical utility and management of patients with pathogenic variants other than BRCA1/2;Critical Reviews in Oncology/Hematology;2024-09

3. Impaired arterial dilation and increased NOX2 generated oxidative stress in subjects with ataxia-telangiectasia mutated (ATM) kinase.;Redox Biology;2024-09

4. Impact of Molecular Profiling on Therapy Management in Breast Cancer;Journal of Clinical Medicine;2024-08-23

5. ATAXIA-telangiectasia with compound heterozygous ATM mutations discovered on abnormal newborn screen;Clinical Immunology;2024-08